A Study to Assess the Effect of Food on the Drug Levels of Admilparant

NCT07225647 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2026-01-14

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of food on the drug levels of Admilparant

Conditions

  • Healthy Participants

Interventions

DRUG

Admilparant

Specified dose on specified days

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-07
Primary Completion
2026-01-05
Completion
2026-01-05
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07225647 on ClinicalTrials.gov